Dr Gotlib discusses the significance of the FDA approval of avapritinib in indolent systemic mastocytosis, key findings from the PIONEER trial, and the quality of life benefits that avapritinib provides for patients in this population.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
